Lessons learnt from the first efficacy trial of a new infant tuberculosis vaccine since BCG.

BACKGROUND: New tuberculosis (TB) vaccines are being developed to combat the global epidemic. A phase IIb trial of a candidate vaccine, MVA85A, was conducted in a high burden setting in South Africa to evaluate proof-of-concept efficacy for prevention of TB in infants. OBJECTIVE: To describe the stu...

Olles dieđut

Bibliográfalaš dieđut
Váldodahkkit: Tameris, M, McShane, H, McClain, J, Landry, B, Lockhart, S, Luabeya, A, Geldenhuys, H, Shea, J, Hussey, G, van der Merwe, L, de Kock, M, Scriba, T, Walker, R, Hanekom, W, Hatherill, M, Mahomed, H
Materiálatiipa: Journal article
Giella:English
Almmustuhtton: 2013